Peer-Reviewed Scientific Publications

There are 100+ peer-reviewed scientific publications relevant to C15:0 and health.

Resources

Highlighted studies

Research Article
IJMS

Aging-Associated Amyloid-β Plaques and Neuroinflammation in Bottlenose Dolphins (Tursiops truncatus) and Novel Cognitive Health-Supporting Roles of Pentadecanoic Acid (C15:0)

Stephanie Venn-Watson, Eric D. Jensent
Published: 16 April 2025

There is an urgent need to identify interventions that broadly target aging-related cognitive decline and progression to Alzheimer’s disease (AD). Two new dose-dependent C15:0 activities (FAAH and MAO-B inhibition) have been found that can lower amyloid-β formation, lower neuroinflammation, and improve cognitive function in relevant animal models. These findings suggest that C15:0 may play a distinct role in supporting cognitive health.

Research Article
The Journal of Nutrition

Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial

Jeffrey B Schwimmer
Published: 26 July 2024

Daily C15:0 supplementation safely increased circulating C15:0 levels in young adults with overweight or obesity. Among participants who achieved C15:0 >5 μg/mL, clinically relevant improvements included lower liver enzymes (ALT and AST) and higher hemoglobin at 12 weeks.

Research Article
metabolites-logo

The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome

Stephanie Venn-Watson
Published: 23 June 2024

Deficiencies in C15:0, an essential fatty acid, can cause fragile cells and a phenomenon called ferroptosis. In turn, ferroptosis accelerates aging and impacts our metabolic, liver, and heart health. This disease, called Cellular Fragility Syndrome, is the first nutritional deficiency syndrome discovered in 75 years. Fixing C15:0 deficiencies effectively strengthens cells, fights ferroptosis, slows cellular aging, and protects our long-term metabolic, liver, and heart health.

Research Article
logo_1

Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid…

Stephanie K. Venn-Watson
Camden N. Butterworth
Published: May 26, 2022

A growing body of evidence supports that pentadecanoic acid (C15:0), an odd-chain saturated fat found in butter, is an essential fatty acid that is necessary in the diet to support long-term metabolic and heart health…

Research Article
logo_2

Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?

Stephanie Venn-Watson
Richard Lumpkin
Edward A. Dennis
Published: 18 May 2020

Dietary odd-chain saturated fatty acids (OCFAs) are present in trace levels in dairy fat and some fish and plants. Higher circulating concentrations of OCFAs, pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0)…

Research Article
logo_2

Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health

Stephanie Venn-Watson
John Reiner
Eric D. Jensen
Published: 23 August 2022

As an emerging dietary essential fatty acid, pentadecanoic acid (C15:0) is expected to have bioactive metabolites with broad health benefits.

Research Article
AJCN-cropped

Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: The TANGO randomized controlled trial

The American Journal of Clinical Nutrition
Published: 29 November 2023

Above and beyond the benefits of a hypo-caloric diet, C15:0 supplementation in this randomized, controlled clinical trial effectively lowered LDL-cholesterol, lowered total fat mass, and caused beneficial shifts in the gut microbiome, including supporting Bifidobacterium adolescentis – a probiotic bacteria that supports longevity.

Research Article
nutrients logo

Pentadecanoic acid (C15:0), an essential fatty acid, shares clinically relevant cell-based activities with leading longevity-enhancing compounds

Stephanie Venn-Watson
Nicholas J. Schork
Published: 30 October 2023

This study, paired the ability of C15:0 to target longevity pathways, hallmarks of aging, and core components of type 2 diabetes, heart disease, cancer, and nonalcoholic fatty liver disease, support C15:0 as an essential nutrient with activities equivalent to, or surpassing, leading longevity-enhancing candidate compounds.

Research Article
Archives of Pharmacology logo

Pentadecanoic acid attenuates thioacetamide-induced liver fibrosis by modulating oxidative stress, inflammation, and ferroptosis pathways in rat

Mohammad Aabis, Priyanka Tiwari, et al.
Published: 01 May 2025

This study looked at a rodent model with liver lipid peroxidation, cell death, dysregulated iron metabolism and immune function and impaired liver function (Cellular Fragility Syndrome) and found that the C15:0 supplemented group had: healthier body weight, lower lipid peroxidation, lower RDW, higher hemoglobin, improved cell survival, restored healthy iron metabolism, lower proinflammatory cytokines and improved liver function.

All studies

Anticancer properties Expand / Close

Antimicrobial properties Expand / Close

Essential fatty acid Expand / Close

Heart health Expand / Close

Immune and joint health Expand / Close

Liver health Expand / Close

Metabolic health Expand / Close

Mood and brain health Expand / Close

Pregnancy, fertility, neonatal development & infant growth Expand / Close

A Vital Lifespan Booster: The Essential Role of C15:0

A Vital Lifespan Booster: The Essential Role of C15:0